These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 33323728

  • 1. [18F]PR04.MZ PET/CT Imaging for Evaluation of Nigrostriatal Neuron Integrity in Patients With Parkinson Disease.
    Juri C, Kramer V, Riss PJ, Soza-Ried C, Haeger A, Pruzzo R, Rösch F, Amaral H, Chana-Cuevas P.
    Clin Nucl Med; 2021 Feb 01; 46(2):119-124. PubMed ID: 33323728
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetic evaluation of [18F]PR04.MZ for PET/CT imaging and quantification of dopamine transporters in the human brain.
    Kramer V, Juri C, Riss PJ, Pruzzo R, Soza-Ried C, Flores J, Hurtado A, Rösch F, Chana-Cuevas P, Amaral H.
    Eur J Nucl Med Mol Imaging; 2020 Jul 01; 47(8):1927-1937. PubMed ID: 31788709
    [Abstract] [Full Text] [Related]

  • 3. SPECT imaging of the dopamine transporter with [(123)I]-beta-CIT reveals marked decline of nigrostriatal dopaminergic function in Parkinson's disease with urinary dysfunction.
    Sakakibara R, Shinotoh H, Uchiyama T, Yoshiyama M, Hattori T, Yamanishi T.
    J Neurol Sci; 2001 Jun 15; 187(1-2):55-9. PubMed ID: 11440745
    [Abstract] [Full Text] [Related]

  • 4. 18F-FP-CIT PET imaging and SPM analysis of dopamine transporters in Parkinson's disease in various Hoehn & Yahr stages.
    Wang J, Zuo CT, Jiang YP, Guan YH, Chen ZP, Xiang JD, Yang LQ, Ding ZT, Wu JJ, Su HL.
    J Neurol; 2007 Feb 15; 254(2):185-90. PubMed ID: 17334953
    [Abstract] [Full Text] [Related]

  • 5. Imaging Nigrostriatal Dopaminergic Deficit in Holmes Tremor with 18F-PR04.MZ-PET/CT.
    Juri C, Chana P, Kramer V, Pruzzo R, Amaral H, Riss PJ, Rösch F.
    Clin Nucl Med; 2015 Sep 15; 40(9):740-1. PubMed ID: 26204203
    [Abstract] [Full Text] [Related]

  • 6. Dopamine transporter imaging does not predict the number of nigral neurons in Parkinson disease.
    Saari L, Kivinen K, Gardberg M, Joutsa J, Noponen T, Kaasinen V.
    Neurology; 2017 Apr 11; 88(15):1461-1467. PubMed ID: 28283599
    [Abstract] [Full Text] [Related]

  • 7. Predictors associated with the rate of progression of nigrostriatal degeneration in Parkinson's disease.
    Yoo HS, Kim HK, Lee HS, Yoon SH, Na HK, Kang SW, Lee JH, Ryu YH, Lyoo CH.
    J Neurol; 2024 Aug 11; 271(8):5213-5222. PubMed ID: 38839638
    [Abstract] [Full Text] [Related]

  • 8. Quantitative Analysis of ¹⁸F-(E)-N-(3-Iodoprop-2-Enyl)-2β-Carbofluoroethoxy-3β-(4'-Methyl-Phenyl) Nortropane Binding to the Dopamine Transporter in Parkinson Disease.
    Fazio P, Svenningsson P, Forsberg A, Jönsson EG, Amini N, Nakao R, Nag S, Halldin C, Farde L, Varrone A.
    J Nucl Med; 2015 May 11; 56(5):714-20. PubMed ID: 25791993
    [Abstract] [Full Text] [Related]

  • 9. Correlation of Parkinson disease severity and 18F-DTBZ positron emission tomography.
    Hsiao IT, Weng YH, Hsieh CJ, Lin WY, Wey SP, Kung MP, Yen TC, Lu CS, Lin KJ.
    JAMA Neurol; 2014 Jun 11; 71(6):758-66. PubMed ID: 24756323
    [Abstract] [Full Text] [Related]

  • 10. Progression of dopaminergic hypofunction in striatal subregions in Parkinson's disease using [18F]CFT PET.
    Nurmi E, Bergman J, Eskola O, Solin O, Vahlberg T, Sonninen P, Rinne JO.
    Synapse; 2003 Jun 01; 48(3):109-15. PubMed ID: 12645035
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease.
    Theisen F, Leda R, Pozorski V, Oh JM, Adluru N, Wong R, Okonkwo O, Dean DC, Bendlin BB, Johnson SC, Alexander AL, Gallagher CL.
    Neuroimage Clin; 2017 Jun 01; 16():557-563. PubMed ID: 28971007
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Multimodal dopaminergic and free-water imaging in Parkinson's disease.
    Yang J, Archer DB, Burciu RG, Müller MLTM, Roy A, Ofori E, Bohnen NI, Albin RL, Vaillancourt DE.
    Parkinsonism Relat Disord; 2019 May 01; 62():10-15. PubMed ID: 30639168
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. An FP-CIT PET comparison of the difference in dopaminergic neuronal loss in subtypes of early Parkinson's disease.
    Song IU, Chung YA, Oh JK, Chung SW.
    Acta Radiol; 2014 Apr 01; 55(3):366-71. PubMed ID: 23943629
    [Abstract] [Full Text] [Related]

  • 19. Reproducibility and effect of levodopa on dopamine transporter function measurements: a [18F]CFT PET study.
    Nurmi E, Bergman J, Eskola O, Solin O, Hinkka SM, Sonninen P, Rinne JO.
    J Cereb Blood Flow Metab; 2000 Nov 01; 20(11):1604-9. PubMed ID: 11083235
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.